— Know what they know.
Not Investment Advice

Financial News

Sentiment 45.3 5294 articles 2872 bullish 1232 bearish Full Index →
KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

Karyopharm Therapeutics stock sinks 18% after mixed phase III data show spleen benefit but no symptom edge for selinexor combo in myelofibrosis,...
KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

Karyopharm Therapeutics stock sinks 18% after mixed phase III data show spleen benefit but no symptom edge for selinexor combo in myelofibrosis,...
Circle Stock Is Volatile - Here's Why

Circle Stock Is Volatile - Here's Why

Circle Internet Group Inc (NYSE:CRCL) stock tumbled on Tuesday after a restrictive Senate draft of a stablecoin bill rattled investors. However,...
📰

Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million

Collegium Pharmaceutical, a leader in abuse-deterrent pain therapies, saw its Chief Commercial Officer trim his stake by more than 40%.
📰

BSX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p>SAN...
📰

CDT Equity announces reverse stock split

📰

CDT Equity announces reverse stock split

📰

BeyondSpring GAAP EPS of -$0.21

📰

Jushi Holdings Inc. Announces First Settlement in Ongoing Hemp-Derived THC Litigation

BOCA RATON, Fla., March 25, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. ("Jushi" or the "Company") (CSE:JUSH) (OTCQX:JUSHF), a vertically...
📰

SEM Shareholder Buyout Investigation Launched by Kaskela Law: Does $16.50 Per Share Buyout Proposal Shortchange Select Medical Shareholders?

PHILADELPHIA, March 25, 2026 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is continuing to investigate the fairness of the $16.50 per...
HOLX vs. ALGN: Which MedTech Stock Is the Better Investment

HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?

Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.
HOLX vs. ALGN: Which MedTech Stock Is the Better Investment

HOLX vs. ALGN: Which MedTech Stock Is the Better Investment Pick Now?

Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug

IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims

ImmunityBio stock sinks 21% after the FDA flags misleading claims on cancer drug Anktiva, citing exaggerated benefits and inadequate risk disclosures.
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug

IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims

ImmunityBio stock sinks 21% after the FDA flags misleading claims on cancer drug Anktiva, citing exaggerated benefits and inadequate risk disclosures.
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug

IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims

ImmunityBio stock sinks 21% after the FDA flags misleading claims on cancer drug Anktiva, citing exaggerated benefits and inadequate risk disclosures.
Absci, DigitalOcean And Other Big Stocks Moving Lower In Wed

Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 1% on Wednesday. Shares of Absci Corp (NASDAQ:ABSI) fell sharply in...
Absci, DigitalOcean And Other Big Stocks Moving Lower In Wed

Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 1% on Wednesday. Shares of Absci Corp (NASDAQ:ABSI) fell sharply in...
📰

Kiora Pharmaceuticals GAAP EPS of -$2.64

📰

AdaptHealth (AHCO) Surges 10.7%: Is This an Indication of Further Gains?

AdaptHealth (AHCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for...
📰

AdaptHealth (AHCO) Surges 10.7%: Is This an Indication of Further Gains?

AdaptHealth (AHCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for...
Assenagon Asset Management S.A. Sells 6,625,644 Shares of Pf

Assenagon Asset Management S.A. Sells 6,625,644 Shares of Pfizer Inc. $PFE

Assenagon Asset Management S.A. lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 76.3% during the 4th quarter, according to its...
Assenagon Asset Management S.A. Sells 6,625,644 Shares of Pf

Assenagon Asset Management S.A. Sells 6,625,644 Shares of Pfizer Inc. $PFE

Assenagon Asset Management S.A. lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 76.3% during the 4th quarter, according to its...
Assenagon Asset Management S.A. Sells 6,625,644 Shares of Pf

Assenagon Asset Management S.A. Sells 6,625,644 Shares of Pfizer Inc. $PFE

Assenagon Asset Management S.A. lessened its position in Pfizer Inc. (NYSE:PFE – Free Report) by 76.3% during the 4th quarter, according to its...
📰

[Latest] Global Patient Mechanical Lift Handling Equipment Market Size/Share Worth USD 4.42 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Patient Mechanical...
MannKind (NASDAQ:MNKD) Sets New 52-Week Low  – Here’s What H

MannKind (NASDAQ:MNKD) Sets New 52-Week Low – Here’s What Happened

MannKind Corporation (NASDAQ:MNKD – Get Free Report) reached a new 52-week low during trading on Wednesday . The company traded as low as $2.25...
Short Interest in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW

Short Interest in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW) Increases By 362.9%

Rocket Pharmaceuticals, Inc. (NASDAQ:RCKTW – Get Free Report) was the target of a large growth in short interest in March. As of March 13th,...
Short Interest in Eaton Vance Intermediate Municipal Income

Short Interest in Eaton Vance Intermediate Municipal Income ETF (NYSEARCA:EVIM) Increases By 309.8%

Eaton Vance Intermediate Municipal Income ETF (NYSEARCA:EVIM – Get Free Report) was the recipient of a large growth in short interest in the...
Merck KGaA (OTCMKTS:MKKGY) Reaches New 12-Month Low  – Time

Merck KGaA (OTCMKTS:MKKGY) Reaches New 12-Month Low – Time to Sell?

Shares of Merck KGaA (OTCMKTS:MKKGY – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as...
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Sees Large Increase

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Sees Large Increase in Short Interest

Relmada Therapeutics, Inc. (NASDAQ:RLMD – Get Free Report) was the recipient of a large growth in short interest in the month of March. As of...
E. Ohman J or Asset Management AB Sells 1,480 Shares of Rege

E. Ohman J or Asset Management AB Sells 1,480 Shares of Regeneron Pharmaceuticals, Inc. $REGN

E. Ohman J or Asset Management AB lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.3% in the 4th...
E. Ohman J or Asset Management AB Sells 1,480 Shares of Rege

E. Ohman J or Asset Management AB Sells 1,480 Shares of Regeneron Pharmaceuticals, Inc. $REGN

E. Ohman J or Asset Management AB lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 34.3% in the 4th...
E. Ohman J or Asset Management AB Reduces Stock Position in

E. Ohman J or Asset Management AB Reduces Stock Position in Becton, Dickinson and Company $BDX

E. Ohman J or Asset Management AB cut its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 41.8% during the fourth...
E. Ohman J or Asset Management AB Reduces Stock Position in

E. Ohman J or Asset Management AB Reduces Stock Position in HCA Healthcare, Inc. $HCA

E. Ohman J or Asset Management AB cut its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 27.2% in the fourth quarter, according to...
E. Ohman J or Asset Management AB Reduces Stock Position in

E. Ohman J or Asset Management AB Reduces Stock Position in HCA Healthcare, Inc. $HCA

E. Ohman J or Asset Management AB cut its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 27.2% in the fourth quarter, according to...
E. Ohman J or Asset Management AB Reduces Stock Position in

E. Ohman J or Asset Management AB Reduces Stock Position in Becton, Dickinson and Company $BDX

E. Ohman J or Asset Management AB cut its position in Becton, Dickinson and Company (NYSE:BDX – Free Report) by 41.8% during the fourth...
E. Ohman J or Asset Management AB Has $2.60 Million Stake in

E. Ohman J or Asset Management AB Has $2.60 Million Stake in Cigna Group $CI

E. Ohman J or Asset Management AB reduced its position in Cigna Group (NYSE:CI – Free Report) by 17.5% during the fourth quarter, according to...
Congress Asset Management Co. Reduces Stake in Zoetis Inc. $

Congress Asset Management Co. Reduces Stake in Zoetis Inc. $ZTS

Congress Asset Management Co. lowered its stake in Zoetis Inc. (NYSE:ZTS – Free Report) by 11.1% in the 4th quarter, according to the company...
Congress Asset Management Co. Reduces Stake in Zoetis Inc. $

Congress Asset Management Co. Reduces Stake in Zoetis Inc. $ZTS

Congress Asset Management Co. lowered its stake in Zoetis Inc. (NYSE:ZTS – Free Report) by 11.1% in the 4th quarter, according to the company...
Congress Asset Management Co. Sells 219,394 Shares of The Co

Congress Asset Management Co. Sells 219,394 Shares of The Cooper Companies, Inc. $COO

Congress Asset Management Co. cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 48.5% during the fourth...
« Prev 1 2 3 4 5 6 23 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms